Page 8 - Johnson Medtech News Today

A total hip replacement procedure available in Taunton and Yeovil has won a prestigious Health Service Journal Partnership Award.

/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, today announced European CE mark...

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, today announced European CE mark approval of the VARIPULSE™ Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA). The VARIPULSE™ Platform is comprised...

J&J announces that Biosense Webster today announced the European CE Mark approval of the Varipulse platform for the treatment of symptomatic drug-refractory paroxysmal atrial fibrillation by pulsed...

Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation 

Johnson & Johnson's Biosense Webster today announced the start of patient cases with the investigational Laminar LAAX system.

The manufacturing of the company's Urinary Bladder Matrix portfolio will move to the Columbia, MA, location.

LivaNova PLC , a market-leading medical technology company, today reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024. Financial Summary and...

LivaNova (Nasdaq:LIVN) shares got a boost today on fourth-quarter results that came in well ahead of the consensus forecast.

CMR Surgical announced that it appointed Sushobhan Dasgupta as president and CCO for Asia Pacific, the Middle East and Africa.